Top Analytics Companies in Delhi (70)

Innovation-Driven Growth: Recent moves pair a planned constellation expansion that combines higher-resolution imaging with higher revisit rates with an AI-centric platform and new 3D offerings. Together, these signal movement up the value chain toward higher-margin software and systems.

Market Expansion: Statements highlight expanding international activity, including a Bundeswehr-focused joint effort, more than a dozen new European customers in 2025, and 60+ government partners. These point to growing geographic reach and customer adoption.

Strategic Partnerships: Collaborations such as a German JV with Rheinmetall for ISR data integration and a build partnership with BAE Systems on next-generation satellites indicate deepening ecosystem ties. Such alliances can accelerate access to new programs and markets.

Market Expansion: The merger with Accolite in 2024, global rebrand in 2025, and the 2026 Cartesian acquisition broadened footprint across North America, Europe, and India. Leadership appointments to run the India practice indicate continued investment in global delivery capacity.

Innovation-Driven Growth: The Cartesian deal was positioned to accelerate enterprise AI capabilities, and joining Anthropic’s Claude Partner Network signals an AI-led services push. Feedback suggests these moves deepen data and analytics strengths rather than retrenchment.

Strategic Partnerships: Recent partner accolades such as Acquia’s 2024 North America Partner of the Year and broader ecosystem momentum point to healthy demand and platform depth. Alliances highlighted across AI and digital experience stacks support go-to-market expansion.

Strong Revenue Growth: Consolidated revenues increased from $253 billion in 2024 to $270.6 billion in 2025, with quarterly gains such as Q4 2025 up 8% year over year. Growth was led primarily by Optum Rx and supported by steady contributions from Optum Insight.

Market Expansion: Expansion through acquisitions such as Holston Medical Group (August 2025) and Alegeus (July 2026), alongside earlier combinations like Change Healthcare and Atrius Health, broadened capabilities across care, pharmacy, and payments. These moves extend Optum’s platform into adjacent services and operating domains.

Diversified Revenue Streams: A multi-segment model—Rx, Insight, and Health—helps sustain aggregate growth even as individual lines vary, with pharmacy and technology businesses offsetting care-delivery softness. Parent-company commentary continuing to frame Optum as a growth engine and raising 2026 guidance underscores the benefit of this portfolio effect.

Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.

Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.

Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.

Strong Market Position & Advantage: Multiple third-party descriptions and industry recognitions portray Kroll as a leading independent provider in financial and risk advisory, with top placements in areas like fairness opinions and investigations/forensics. Scale signals such as a global workforce and long operating history reinforce a durable competitive position.

Market Expansion: Evidence points to active expansion through new practices (e.g., Economics and Decision Intelligence), geographic build-outs, and acquisitions across regions including APAC, Europe, and Latin America. Announcements of added services and locations indicate an expanding footprint.

Diversified Revenue Streams: A broad portfolio spanning valuation, investigations, due diligence, compliance, cyber/MDR/IR, restructuring, and agency/trustee services suggests multiple demand drivers. Recognition across several distinct service lines implies revenue is not dependent on a single offering.

Strong Revenue Growth: Independent growth recognitions indicate multi-year expansion, including repeated placements on fast-growing company lists and cited multi-year revenue growth through 2024. Continued growth signals are also reinforced by ongoing mentions of consecutive years of expansion into late 2025.

Strategic Partnerships: Large financial-institution deployments and expansions (e.g., major bank rollouts and additional bank use cases beyond SBA lending) demonstrate partner-led distribution and credibility with regulated lenders. Additional ecosystem tie-ups and collaborations referenced in the data suggest continued channel expansion.

Future-Ready Strategy: The company is repeatedly described as leaning into AI-driven underwriting and related product investments, aligning its roadmap with broader market direction in automated cash-flow decisioning. This forward-oriented product direction is presented as a factor supporting ongoing resilience across cycles.

Strong Market Position & Advantage: Elsevier is widely regarded as a dominant force in STM publishing with flagship journals (e.g., The Lancet, Cell) and critical platforms like ScienceDirect and Scopus. Feedback suggests this entrenched position supports stable demand and reinforces its central role in research and clinical workflows.

Profitability: The business delivers strong profits with high operating margins and contributes materially to its parent company’s earnings. Feedback suggests profitability has remained robust alongside increased article output and heavy platform usage.

Innovation-Driven Growth: The company is shifting toward higher-growth analytics and AI-enabled tools and expanding through targeted healthcare tech acquisitions. Feedback suggests rapid growth in open access output and new AI-assisted research tools positions the business well for future demand.

Strong Market Position & Advantage: Industry evaluations consistently place Atlan as a Leader across Gartner and Forrester reports spanning metadata management, data governance, and enterprise data catalogs. This repeated third-party validation indicates durable competitive positioning in core markets.

Strong Revenue Growth: The company reports revenues growing more than sevenfold over two years, alongside a sharp increase in enterprise sales. Named enterprise customers and expanding adoption signal commercial momentum tied to AI data readiness and governance demand.

Investor Backing & Capital Strength: A $105 million Series C in May 2024 increased total capital to over $200 million and adds runway for global go-to-market and AI product investment. Participation by prominent investors and an elevated valuation reflect external confidence in the growth plan.

Strategic Partnerships: Partnerships with hyperscalers and advisors (e.g., multi-year AWS collaboration, 2025 AWS Partner Award, and a 2026 AI-focused venture with Teneo) broaden the company’s go-to-market in AI and data services. Industry recognitions and joint initiatives are positioned to unlock new enterprise opportunities even as recent financial visibility is limited.

Future-Ready Strategy: The company is pivoting to an AI-first model, launching AI/works and advancing 50+ generative AI projects, while Technology Radar and “AI-First Consulting Firm” recognition underscore focus on emerging tech. These moves target rising demand for AI-enabled delivery and data engineering.

Cost & Operational Efficiency: Restructuring across 2023–2024 generated substantial annualized savings (e.g., $87M by Q1 2024 and about $180M by September 30, 2024), reflecting disciplined cost control. Actions indicate a concerted effort to restore margins and resilience amid softer demand.

Strong Revenue Growth: Feedback suggests the company is delivering double-digit year-over-year revenue increases with a strong quarterly exit run-rate, underpinned by growth in USD operating revenue. Headcount expansion and ongoing deal momentum further corroborate top-line traction.

Profitability: Evidence indicates rising net profit with steady margins and EPS growth, reflecting operating discipline alongside scale. This profitability trend appears sustained across recent quarters and the full fiscal year.

Strong Market Position & Advantage: Feedback suggests the firm holds recognized leadership in defined niches—most notably as a Leader in capital markets operations—while maintaining credible positions in areas like digital shelf analytics and CXM. This domain depth and productized solutions orientation support competitive differentiation.